COPD: Rethinking Patient Management - How to Approach a Challenging Patient Group Successfully.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
2019
Historique:
received: 12 09 2018
accepted: 12 09 2018
pubmed: 18 3 2019
medline: 7 8 2020
entrez: 18 3 2019
Statut: ppublish

Résumé

In comparison to other chronically ill people, patients suffering from chronic obstructive pulmonary disease (COPD) have many additional difficulties to face and conquer. Due to the contribution of avoidable causes of their illness ("smokers' lung"), society holds people with COPD responsible for their disease, which in return often leads to stigmatization and social isolation. In addition, COPD patients commonly belong to a less privileged social class, own a low socioeconomic status, and lower education. Their physical symptoms are easily observable and - by employing moderate adherence - treatable. Nonetheless, the influence of COPD on a patient's psyche often plays an overly prominent role during therapy. "There is only half a patient laying on the examination table," a revelation that sums up the current state of COPD research and the result of the expert meeting "Luftschlösser" ("castles in the clouds"), which took place in spring 2018. Within the limits of the meeting, participants identified practically applicable approaches aiming to enhance the patient management of this challenging patient group. These considerations are supposed to support healthcare professionals in their daily work and aim to improve the therapy as well as the outcome for COPD patients.

Identifiants

pubmed: 30879009
pii: 000493759
doi: 10.1159/000493759
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-368

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Berthold H Jany (BH)

Department of Respiratory Medicine, Klinikum Würzburg Mitte gGmbH, Würzburg, Germany, bert.jany@t-online.de.

Robert Bals (R)

Department of Internal Medicine V - Pulmonology, Allergology, and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.

Heike Buhr-Schinner (H)

Pneumology, Ostseeklinik Schönberg-Holm, Schönberg, Germany.

Michael Dreher (M)

Department of Pneumology and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany.

A Rembert Koczulla (AR)

Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.
Department of Respiratory Medicine and Pulmonary Rehabilitation, Schön Klinik Berchtesgadener Land, Schönau am Königssee, Germany.

Luitgard Jany (L)

Clinical Psychology Practice, Würzburg, Germany.

Andreas Meyer (A)

Respiratory Medicine, Allergology and Sleep Medicine, Kliniken Maria Hilf, Mönchengladbach, Germany.

Winfried Randerath (W)

Clinic for Pneumology and Allergology, Centre of Sleep Medicine and Respiratory Care, Bethanien Hospital, Institute of Pneumology, University of Cologne, Solingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH